Arovella has raised $12.5m to advance its lead product, ALA-101, into phase 1 first-in-human clinical trials.
• Specifically, funds raised will be used to:
• Complete GMP manufacture of ALA-101 for phase 1
• Complete IND-enabling non-clinical safety and efficacy studies to support a phase 1 study in CD19+ B cell malignancies
• Commence and advance phase 1 clinical trial for ALA-101 and generate human data
• Continue development of additional pipeline products including ALA-105, IL-12-TM and future partnerships Offer Details
• $12.5 million Placement (“Placement”.
• The Offer was priced at $0.10 per New Share (“Offer Price”, which represents a:
• 23.1% discount to last close on 21 March 2024
• The Offer includes a 1-for-1 attaching Option with an exercise price of $0.15 and an expiry date of 3 years from date of issue.
• As at 31 December 2023, Arovella had net cash of $4.8 million. Post the offer, the Company will have a pro-forma cash balance (net of offer costs) of approximately $16.5 million. The Company also expects an R&D Tax Incentive receivable for FY24 of ~$3.5 million to be received in Q4 2024.
------------------------------------------------------------------------------------------------------
$12.5 million fair whack of cash, but guess it'll get joint a long way down road and by then we will know what we know.
- Forums
- ASX - By Stock
- Ann: Investor Presentation
Arovella has raised $12.5m to advance its lead product, ALA-101,...
Featured News
Add ALA (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $126.0M |
Open | High | Low | Value | Volume |
12.5¢ | 12.5¢ | 12.0¢ | $48.97K | 396.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 434471 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 137017 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 434471 | 0.120 |
11 | 585267 | 0.115 |
11 | 521172 | 0.110 |
21 | 811141 | 0.105 |
22 | 1112940 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 137017 | 3 |
0.130 | 419630 | 5 |
0.135 | 301083 | 6 |
0.140 | 162366 | 5 |
0.145 | 54535 | 2 |
Last trade - 16.10pm 29/04/2024 (20 minute delay) ? |
|
|||||
Last
12.3¢ |
  |
Change
0.000 ( 2.08 %) |
|||
Open | High | Low | Volume | ||
12.5¢ | 12.5¢ | 12.0¢ | 291002 | ||
Last updated 15.08pm 29/04/2024 ? |
Featured News
ALA (ASX) Chart |